Wataru Ichikawa

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial

Kazuhiro Yoshida, Yasuhiro Kodera, Mitsugu Kochi et al. · Journal of Clinical Oncology · 2019 · 381 citations · Full text

Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer

Masanori Terashima, Koji Kitada, Atsushi Ochiai et al. · Clinical Cancer Research · 2012 · 225 citations · Full text

Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.

Wataru Ichikawa, Hiroyuki Uetake, Yoshinori Shirota et al. · PubMed · 2003 · 154 citations

Surgical Oncology, Fluoropyrimidine-based Chemotherapy, Medicine +13

Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma

Ryo Ohno, Keigo Yoshinaga, Takeshi Fujita et al. · Cancer · 2001 · 135 citations

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer

Wataru Ichikawa, Hiroyuki Uetake, Yoshinori Shirota et al. · British Journal of Cancer · 2003 · 128 citations · Full text